NIH-funded research Fellowship grant

Understanding how natural killer cells respond to COVID-19 variants

Official title: Defining factors affecting natural killer cells' antibody-dependent responses in COVID-19

Funded at Stanford University · NIH-10899178 · Data updated 2026-11-12

This study is looking at how special immune cells called natural killer (NK) cells react to different COVID-19 variants, especially in people who have been vaccinated or are on treatments that weaken their immune system, to find ways to boost our body's ability to fight the virus and improve future treatments or vaccines.

More COVID-19 research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2027
Funding year2024
Award (this year)$42,293
NIH project number1F31AI179125-01A1
Project IDNIH-10899178 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have been vaccinated against COVID-19 or those who have experienced COVID-19 infection.

Less likely to help

Patients who are not affected by COVID-19 or who have not received any form of vaccination may not benefit from this research.

What this research studies

This research investigates how natural killer (NK) cells, a type of immune cell, respond to COVID-19 variants that may evade the immune system. The study aims to identify factors that influence NK cells' ability to target and destroy virus-infected cells, particularly in the context of vaccination and immunosuppressive treatments. By examining the interactions between NK cells and antibodies, the research seeks to uncover mechanisms that could enhance immune responses against COVID-19. Patients may benefit from insights that could lead to improved treatments or vaccines.

Why it matters

Potential benefit: If successful, this research could lead to better strategies for enhancing immune responses against COVID-19, potentially improving patient outcomes.

How similar studies have gone: Other research has shown promise in understanding immune responses to viral infections, making this approach both relevant and potentially impactful.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Chan, Leslie — Stanford University
  • Study coordinator: Chan, Leslie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.